TABLE 2.

Planned cumulative chemotherapy exposures by regimen.

	ABVD (6–8 cycles; 24–32 weeks)	Stanford V (12 weeks)	ABVE-PC (4 cycles; 12 weeks)	DECA (2 cycles; 6 weeks)
	Planned cumulative exposure
Doxorubicin	300–400 mg/m2	150 mg/m2	200 mg/m2	---
Bleomycin	120–180 U/m2	30 U/m2	60 U/m2	---
Vinblastine	72–96 mg/m2	36 mg/m2	---	---
Vincristine	---	8.4 mg/m2	11.2 mg/m2	---
Dacarbazine	4.5–6.0 g/m2	---	---	---
Cyclophosphamide	---	---	3.2 g/m2	---
Mechlorethamine	---	18 mg/m2	---	---
Etoposide	---	360 mg/m2	1,500 mg/m2	400 mg/m2
Prednisone	---	~420 mg/m2*	1,120 mg/m2	---
Dexamethasone	---	---	---	40 mg/m2
Cytarabine	---	---	---	12 g/ m2
Cisplatin	---	---	---	180 mg/m2

^*Cumulative dose does not reflect taper in weeks 10–12.